These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6213001)

  • 1. [Use of laparoscopy in the diagnosis of hepatic steatosis].
    De la Revilla L; Martiń-Vivaldi R; Cano Bueso F
    Rev Esp Enferm Apar Dig; 1982 Mar; 61(3):218-24. PubMed ID: 6213001
    [No Abstract]   [Full Text] [Related]  

  • 2. [Massive hepatic steatosis].
    Bruguera M; Teres J; Rodes J; Bordas JM
    Rev Clin Esp; 1971 Jul; 122(2):135-40. PubMed ID: 5164621
    [No Abstract]   [Full Text] [Related]  

  • 3. Liver steatosis quantification using magnetic resonance imaging: a prospective comparative study with liver biopsy.
    Mennesson N; Dumortier J; Hervieu V; Milot L; Guillaud O; Scoazec JY; Pilleul F
    J Comput Assist Tomogr; 2009; 33(5):672-7. PubMed ID: 19820490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatic steatosis].
    Zelasco JF; Bordolí DJ; Genaro O
    Med Panam; 1964 Jan; 22(1):10-9. PubMed ID: 5900012
    [No Abstract]   [Full Text] [Related]  

  • 5. Spectrum of histological features in non-alcoholic fatty liver disease.
    Vasdev N; Kakati AG; Saigal S; Nayak NC
    Natl Med J India; 2007; 20(6):282-7. PubMed ID: 18335793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Non-alcoholic steato-hepatitis].
    Linhart HG
    Praxis (Bern 1994); 2000 May; 89(22):963-6. PubMed ID: 10893995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Incidence and etiopathogenic aspects of hepatic steatosis. Review of 1,534 autopsies].
    Alcántara Torres M; Cano López JM; Castellano G; Segura Cabral JM; Larrauri J; Muro González J
    Rev Clin Esp; 1981 Apr; 161(2):79-83. PubMed ID: 7280324
    [No Abstract]   [Full Text] [Related]  

  • 8. Dual-echo, chemical shift gradient-echo magnetic resonance imaging to quantify hepatic steatosis: Implications for living liver donation.
    Rinella ME; McCarthy R; Thakrar K; Finn JP; Rao SM; Koffron AJ; Abecassis M; Blei AT
    Liver Transpl; 2003 Aug; 9(8):851-6. PubMed ID: 12884199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body mass index as a predictor of hepatic steatosis in living liver donors.
    Rinella ME; Alonso E; Rao S; Whitington P; Fryer J; Abecassis M; Superina R; Flamm SL; Blei AT
    Liver Transpl; 2001 May; 7(5):409-14. PubMed ID: 11349260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors.
    Peng D; Han Y; Ding H; Wei L
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1082-8. PubMed ID: 18707599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical, biochemical, scintigraphic and histological diagnosis of advanced liver steatosis].
    Stránský J; Polomis V; Lomská L; Kaspárková J; Vodák M; Sprincl L
    Vnitr Lek; 1981 Feb; 27(2):105-14. PubMed ID: 7467152
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hepatic steatosis in aged diabetics].
    Zrůstová M; Rostlapil J
    Acta Univ Carol Med (Praha); 1966; 12(6):405-9. PubMed ID: 6003750
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of hepatic steatosis by expert pathologists: the end of a gold standard.
    El-Badry AM; Breitenstein S; Jochum W; Washington K; Paradis V; Rubbia-Brandt L; Puhan MA; Slankamenac K; Graf R; Clavien PA
    Ann Surg; 2009 Nov; 250(5):691-7. PubMed ID: 19806055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ultrasonography in the diagnosis of fatty liver (author's transl)].
    Spuhler A; Pösl H; Sander R; Götz U
    Leber Magen Darm; 1981 Jan; 11(1):15-20. PubMed ID: 6452560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse multinodular hepatic steatosis of metastatic appearance. A case description.
    Amoyal P; Bauret P; Bories P; Michel H
    Endoscopy; 1989 Jul; 21(4):193-4. PubMed ID: 2528449
    [No Abstract]   [Full Text] [Related]  

  • 16. Focal hepatic steatosis that appears as a liver mass in imaging.
    Kim JH; Yim HJ; Yeom SK
    Clin Gastroenterol Hepatol; 2011 May; 9(5):e45. PubMed ID: 21145424
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical significance and diagnosis of fatty liver in Taiwan.
    Leung KW; Liu JD; Chen PH; Wang CS; Wang CK; Huang MJ; Siauw CP; Yuan CY; Chen TY
    Taiwan Yi Xue Hui Za Zhi; 1986 Feb; 85(2):149-60. PubMed ID: 2942633
    [No Abstract]   [Full Text] [Related]  

  • 18. [Case of massive hepatic steatosis secondary to thiamine abuse].
    Buligescu L; Milcu V; Serbănescu M; Georgescu S; Popescu S; Muscaliuc I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1986; 38(2):183-92. PubMed ID: 2875508
    [No Abstract]   [Full Text] [Related]  

  • 19. [Relationship between the severity of liver damage and the serum leptin level for nonalcoholic fatty liver disease].
    Kim KO; Park SH; Park CH; Han TH; Yoo KS; Kim JH; Lee MS; Kim DJ; Park CK; Cho HD
    Korean J Hepatol; 2005 Mar; 11(1):51-8. PubMed ID: 15788885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy.
    Javor ED; Ghany MG; Cochran EK; Oral EA; DePaoli AM; Premkumar A; Kleiner DE; Gorden P
    Hepatology; 2005 Apr; 41(4):753-60. PubMed ID: 15791619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.